Rapport Therapeutics RAPP
NASDAQ RAPP
$33.02 -0.42 (-1.26%)
At close: Sep 29, 2026 · 4:00 PM EDT

Rapport Therapeutics (RAPP) Operating Margin (2026)

Updated

Rapport Therapeutics (RAPP) reported Operating Margin of -121.08% for Q1 2026.

Analysis

Rapport Therapeutics (RAPP) Operating Margin (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Rapport Therapeutics 1.60 Bn 1.60 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -121.08%
API Access

Rapport Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=RAPP&period=max&api_key=YOUR_API_KEY